...
首页> 外文期刊>Pathology oncology research: POR >Chromogenic In Situ Hybridization Analysis of Epidermal Growth Factor Receptor Gene/Chromosome 7 Numerical Aberrations in Hepatocellular Carcinoma Based on Tissue Microarrays
【24h】

Chromogenic In Situ Hybridization Analysis of Epidermal Growth Factor Receptor Gene/Chromosome 7 Numerical Aberrations in Hepatocellular Carcinoma Based on Tissue Microarrays

机译:基于组织芯片的肝细胞表皮生长因子受体基因/第7染色体染色体色差的原位杂交分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Although Epidermal Growth Factor Receptor (EGFR) overexpression is observed frequently in hepatocellular carcinomas (HCC), specific gene deregulation mechanisms remain unknown. Our aim was to investigate the prognostic significance of the combined protein and gene/chromosome 7 numerical alterations. Using tissue microarray technology, thirty-five (n?=?35) paraffin embedded histologically confirmed HCCs were cored and re-embedded in a paraffin block. Immunohistochemistry was performed for the determination of EGFR protein levels and evaluated by the performance of digital image analysis. Chromogenic in situ hybridization was also performed based on the use of EGFR gene and chromosome 7 centromeric probes, respectively. EGFR overexpression was observed in 26/35 (74.2%) cases and was correlated to the grade of the tumors and also to the history of the patients (p?=?0.013, p?=?0.036, respectively). Numerical alterations regarding gene and chromosome 7 were identified in 4/35 (11.4%) and 12/35 (43.2%) cases associated to the grade of the tumors (p?=?0.019, p?=?0.001, respectively) and to the survival rate of the patients (p?=?0.037, p?=?0.001, respectively). EGFR overall expression was also correlated to the gene copies (p?=?0.020). EGFR gene numerical alterations –although rare– and also chromosome 7 aneuploidy maybe affect prognosis in HCC patients. To our knowledge this is the first chromogenic in situ hybridization analysis based on tissue microarrays in hepatocellular carcinoma.
机译:尽管在肝细胞癌(HCC)中经常观察到表皮生长因子受体(EGFR)的过表达,但是具体的基因失调机制仍然未知。我们的目的是研究组合的蛋白质和基因/染色体7数值变化的预后意义。使用组织微阵列技术,将经组织学确认的HCC包埋的35种( n ?=?35)石蜡包埋,然后重新嵌入石蜡块中。进行免疫组织化学测定EGFR蛋白水平,并通过数字图像分析的性能进行评估。还分别基于EGFR基因和7号染色体着丝粒探针的使用,进行了生色原位杂交。在26/35(74.2%)的病例中观察到EGFR过表达,并且与肿瘤的分级以及患者的病史相关( p? =?0.013,< em class =“ EmphasisTypeItalic”> p ?=?0.036)。在与肿瘤等级相关的4/35(11.4%)和12/35(43.2%)病例中发现了有关基因和7号染色体的数字变化( p ?=? 0.019,分别为 p ?=?0.001)和患者的生存率( p ?=?0.037,< em class =“ EmphasisTypeItalic”> p ?=?0.001)。 EGFR的总体表达也与基因拷贝相关( p ?=?0.020)。 EGFR基因的数字变化(尽管很罕见)以及7号染色体非整倍性可能会影响HCC患者的预后。据我们所知,这是首次基于肝细胞癌组织芯片的生色原位杂交分析。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号